For patients with Crohn's disease or ulcerative colitis who have exhausted other treatment options, a new combination therapy is showing results that offer hope for one of medicine's most ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted other treatment options, according to findings from two new trials.

In the management of Crohn’s disease, a key objective — preserving the bowel by reducing the need for multiple resections — is gaining ground. Advances in treat-to-target (T2T) and perioperative ...